Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-116481
Filing Date
2021-04-14
Accepted
2021-04-14 17:16:59
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A d152560ddefa14a.htm DEFA14A 39341
2 GRAPHIC g152560g22i22.jpg GRAPHIC 57998
3 GRAPHIC g152560naa1.jpg GRAPHIC 9465
4 GRAPHIC g152560naa22.jpg GRAPHIC 41922
5 GRAPHIC g152560sp002.jpg GRAPHIC 1224
  Complete submission text file 0001193125-21-116481.txt   182555
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-00100 | Film No.: 21826439
SIC: 2834 Pharmaceutical Preparations